Genc Hudai, Morita Eugene, Perrier Nancy D, Miura Daisha, Ituarte Philip, Duh Quan-Yang, Clark Orlo H
Department of Surgery, Mount Zion Medical Center, University of California at San Francisco, 1600 Divisadero Street, San Francisco, CA 94143-1674, USA.
J Am Coll Surg. 2003 Apr;196(4):535-40. doi: 10.1016/s1072-7515(03)00108-x.
Minimally invasive parathyroid surgery with intraoperative parathyroid hormone testing has been reported to be as successful as a bilateral operation. This study aimed to determine whether the histologic findings and outcomes differ in patients with primary sporadic hyperparathyroidism treated by a focal or a bilateral parathyroid exploration with intraoperative parathyroid hormone testing. To make the two groups comparable all patients had a solitary parathyroid adenoma identified preoperatively.
Eighty unselected patients with primary hyperparathyroidism and a single abnormal parathyroid gland identified preoperatively by sestamibi scanning or ultrasonography were included in this study. All patients had intraoperative parathyroid hormone testing.
Forty-five patients had standard bilateral neck explorations and 35 patients had focal neck explorations. In the bilateral neck exploration group a single adenoma was found in 38 patients (84%), a double adenoma in 3 patients (7%), hyperplasia in 3 patients (7%), and carcinoma in 1 patient (2%). In contrast, a single adenoma was identified in all patients in the focal neck exploration group. Sestamibi scanning and intraoperative parathyroid hormone assay were accurate in 87% and 84%, respectively, in the bilateral neck exploration group and in 96.9% and 94.3%, respectively, in the focal neck exploration group. All patients were normocalcemic (mean followup 17 months).
Patients with primary hyperparathyroidism having a bilateral exploration had about a 15% higher rate of multiple parathyroid tumors than did patient having a focal approach. Despite this observation all patients were normocalcemic postoperatively. This suggests that either some histologically abnormal parathyroid glands do not function or there will be recurrences in patients treated by a focused approach. Longterm followup will be necessary to determine whether patients treated by focal neck exploration will develop recurrent primary hyperparathyroidism.
据报道,术中进行甲状旁腺激素检测的微创甲状旁腺手术与双侧手术一样成功。本研究旨在确定在原发性散发性甲状旁腺功能亢进患者中,采用局部或双侧甲状旁腺探查并术中进行甲状旁腺激素检测时,组织学结果和手术效果是否存在差异。为使两组具有可比性,所有患者术前均确诊为单发甲状旁腺腺瘤。
本研究纳入了80例未经筛选的原发性甲状旁腺功能亢进患者,这些患者术前通过锝[99mTc]甲氧基异丁基异腈扫描或超声检查确定有一个异常甲状旁腺。所有患者均进行了术中甲状旁腺激素检测。
45例患者接受了标准的双侧颈部探查,35例患者接受了局部颈部探查。在双侧颈部探查组中,38例患者(84%)发现单发腺瘤,3例患者(7%)发现双发腺瘤,3例患者(7%)发现增生,1例患者(2%)发现癌。相比之下,局部颈部探查组的所有患者均发现单发腺瘤。双侧颈部探查组中,锝[99mTc]甲氧基异丁基异腈扫描和术中甲状旁腺激素测定的准确率分别为87%和84%,局部颈部探查组中分别为96.9%和94.3%。所有患者血钙均正常(平均随访17个月)。
原发性甲状旁腺功能亢进患者接受双侧探查时,多发甲状旁腺肿瘤的发生率比接受局部手术的患者高约15%。尽管如此,所有患者术后血钙均正常。这表明,要么一些组织学上异常的甲状旁腺无功能,要么接受局部手术的患者会复发。需要长期随访以确定接受局部颈部探查的患者是否会发生复发性原发性甲状旁腺功能亢进。